What is included in this Sample?
- * Market Segmentation
- * Key Findings
- * Research Scope
- * Table of Content
- * Report Structure
- * Report Methodology
Download FREE Sample Report
Peritoneal Dialysis Market Size, Share, Growth, And Industry Analysis By Type (Peritoneal Dialysis Machine, Peritoneal Dialysis Solution and Others) By Application (CAPD, APD and Others), Regional Insights and Forecast From 2026 To 2035
Trending Insights
Global Leaders in Strategy and Innovation Rely on Our Expertise to Seize Growth Opportunities
Our Research is the Cornerstone of 1000 Firms to Stay in the Lead
1000 Top Companies Partner with Us to Explore Fresh Revenue Channels
PERITONEAL DIALYSIS MARKET OVERVIEW
The global peritoneal dialysis market is estimated to be valued at USD 0.17 Billion in 2026. The market is projected to reach USD 0.29 Billion by 2035, expanding at a CAGR of 6.1% from 2026 to 2035.
I need the full data tables, segment breakdown, and competitive landscape for detailed regional analysis and revenue estimates.
Download Free SampleThe peritoneal dialysis market is shaped by the growing burden of chronic kidney disease, which affects approximately 850 million people worldwide. Peritoneal dialysis uses the lining of the abdomen as a natural filter, allowing patients to remove waste and excess fluid at home without frequent hospital visits. Approximately 11% of all dialysis patients globally rely on this therapy, making it the most widely used home dialysis modality. The peritoneal dialysis market benefits from policy support for home therapies, lower infrastructure needs compared with in-center hemodialysis, and improving patient training programs. Manufacturers are focusing on automated cyclers, biocompatible solutions, and remote monitoring to improve adherence and reduce peritonitis risk across developed and emerging healthcare systems.
In the United States, peritoneal dialysis has gained momentum through federal initiatives that encourage home-based kidney care. Payment reforms for end-stage kidney disease treatment now reward providers that increase the use of home dialysis, and this has pushed large dialysis organizations to expand training clinics and nurse support for peritoneal dialysis patients. Demand is also supported by an aging population, a high prevalence of diabetes and hypertension, and growing patient preference for treatment that fits around work and family life. Domestic suppliers are strengthening solution manufacturing capacity after past supply disruptions, while telehealth visits and connected cyclers are helping clinicians monitor therapy from a distance and manage complications earlier.
KEY FINDINGS
- Type Leadership: Peritoneal dialysis solution leads the type segment with a 62% share, driven by recurring consumption, daily patient use, and demand for low-glucose formulations.
- Application Leadership: CAPD holds a 54% share of the application segment, supported by low equipment cost, manual simplicity, and strong adoption in emerging economies.
- Key Company Landscape: Baxter and Fresenius lead the competitive landscape through broad solution portfolios, automated cycler innovation, global distribution networks, and integrated home dialysis training programs.
- Leading Regional Market: Asia Pacific dominates the regional analysis with a 38% share, supported by large patient pools, government PD First policies, and local manufacturing growth.
- Key Trends: Remote patient monitoring, biocompatible solutions, and automated systems are reshaping care, while APD already accounts for a 38% share of applications.
LATEST TRENDS
Automated peritoneal dialysis, remote patient monitoring, biocompatible solutions, and home-first care models
The most visible trend in the peritoneal dialysis market is the shift toward automated systems that connect patients and clinicians through digital platforms. Automated peritoneal dialysis already holds a 38% share of the application landscape, and cyclers with cloud connectivity allow nephrology teams to review therapy data, ultrasound-free fluid balance trends, and missed sessions without requiring a clinic visit. This approach lowers hospital admissions and supports earlier intervention when a patient shows signs of infection or fluid overload.
Another strong trend is the development of biocompatible solutions with low glucose degradation products and neutral pH. These formulations help protect the peritoneal membrane over long treatment periods, which extends the time patients can remain on therapy. Icodextrin and amino acid based solutions are also gaining attention for patients who struggle with fluid removal or nutrition.
PERITONEAL DIALYSIS MARKET SEGMENTATION
By Type
Based on Type the global market can be categorized in to Peritoneal Dialysis Machine, Peritoneal Dialysis Solution, and Others.
- Peritoneal Dialysis Machine: The peritoneal dialysis machine segment accounts for a 28% share of the peritoneal dialysis market. These automated cyclers deliver and drain dialysate while the patient sleeps, which frees daytime hours for work, school, and family. Modern machines include programmable therapy profiles, alarms, touchscreen interfaces, and data cards or wireless modules that send treatment records to the clinic. Demand is supported by the rise of APD, the need for gentler fluid exchanges, and the growing use of assisted therapy for older patients. Manufacturers are working on lighter, quieter, and more portable designs, and they continue to improve disposable tubing sets, which create recurring demand around every installed device.
- Peritoneal Dialysis Solution: The peritoneal dialysis solution segment leads the peritoneal dialysis market with a 62% share. Dialysate bags are consumed every day, so this segment benefits from steady and predictable demand regardless of device sales cycles. Glucose-based solutions remain the standard, yet low glucose degradation product bags, icodextrin for long dwells, and amino acid formulations are gaining use because they help protect the peritoneal membrane and improve ultrafiltration. Local manufacturing in Asia Pacific is increasing supply and reducing import dependence.
- Others: The others segment holds a 10% share and includes catheters, transfer sets, connectors, disinfecting caps, drain bags, and monitoring accessories. Although smaller in share, these products are essential to safe therapy because infection prevention depends on reliable connections and clean technique. Peritoneal dialysis catheter placement is performed by nephrologists, surgeons, and interventional radiologists, and procedural quality has a direct effect on technique survival. Demand is rising as more patients begin home therapy and as hospitals standardize training kits. Innovation focuses on pre-attached systems, antimicrobial coatings, and simplified connectors that reduce errors and lower the risk of peritonitis in new users.
By Application
Based on Application the global market can be categorized in to CAPD, APD, and Others.
- CAPD (Continuous Ambulatory Peritoneal Dialysis): Continuous ambulatory peritoneal dialysis leads the application segment with a 54% share in the peritoneal dialysis market. Patients perform manual exchanges several times a day using gravity, with no electricity or cycler required. This makes CAPD attractive in regions with limited infrastructure, in rural communities, and in public health programs that prioritize low-cost therapy. Training is straightforward, and patients keep independence while maintaining flexible schedules. Solution consumption in CAPD is high because each exchange requires a new bag, so the segment contributes strongly to the leading position of dialysis solutions.
- APD (Automated Peritoneal Dialysis): Automated peritoneal dialysis holds a 38% share of the peritoneal dialysis market and is the fastest growing application. A cycler performs exchanges overnight, which leaves patients free during the day and often improves quality of life. APD suits working adults, children, and patients who need tailored dwell times or tidal programs. Remote monitoring software allows clinicians to review therapy adherence and adjust prescriptions without extra visits. Higher device costs and training needs are balanced by lower exchange burden and better patient satisfaction. Wider reimbursement for home therapies in developed economies is expanding APD use, and new compact cyclers are reaching more patients in developing economies.
- Others: The others application segment accounts for an 8% share and includes assisted peritoneal dialysis, incremental peritoneal dialysis, urgent start therapy, and acute peritoneal dialysis used in hospitals. Assisted programs in which nurses or trained caregivers perform exchanges help frail and older adults remain at home, and several European countries have expanded these services. Urgent start protocols let patients begin therapy within days of catheter placement, which reduces reliance on temporary hemodialysis catheters. Acute peritoneal dialysis has also been used in resource-limited settings and in pediatric intensive care when hemodialysis is not available.
MARKET DYNAMICS
Driving Factor
Rising prevalence of chronic kidney disease and preference for home-based therapy
Chronic kidney disease affects approximately 850 million people worldwide, and diabetes and hypertension remain the leading causes of progression to kidney failure. As more patients reach dialysis, health systems are looking for treatment models that lower hospital burden and improve patient autonomy. Peritoneal dialysis fits this need because it can be performed at home with simple infrastructure and without vascular access surgery. It also preserves residual kidney function longer in many patients, which supports better outcomes during early dialysis years. Payers value lower per-patient facility costs, while patients value flexible schedules and fewer clinic visits. Government initiatives that promote home dialysis, together with expanded nurse training and reimbursement alignment, continue to support adoption across both developed and emerging countries.
Driver Impact Analysis*
| Market Drivers | CAGR Contribution | 2026–2028 | 2029–2031 | 2032–2035 |
|---|---|---|---|---|
| Increasing prevalence of chronic kidney disease and end-stage kidney disease worldwide | +2.20% | High | High | High |
| Growing preference for home-based dialysis and patient-centered renal care | +1.85% | High | High | High |
| Rising geriatric population and increasing incidence of diabetes and hypertension | +1.50% | High | High | Medium |
| Technological advancements in automated peritoneal dialysis cyclers and remote patient monitoring | +1.25% | Medium | High | High |
| Expansion of healthcare reimbursement programs and government support for home dialysis therapies | +1.00% | Medium | High | High |
| Others – Increasing patient education, improved dialysis training programs, and expansion of renal care services | +0.50% | Low | Medium | Medium |
Restraining Factor
Risk of peritonitis and limited patient awareness
Peritonitis remains the most serious complication of peritoneal dialysis and a leading reason patients switch to hemodialysis. Infections can occur from contaminated connections, catheter exit site problems, or poor hand hygiene, and repeated episodes damage the peritoneal membrane. Many patients also receive limited information about modality choice before starting dialysis, so peritoneal dialysis is often not discussed as an option. Approximately 11% of dialysis patients worldwide use this therapy, which suggests that awareness, referral habits, and clinic incentives still favor in-center hemodialysis in many markets. Fear of self-care, lack of caregiver support, and unsuitable housing conditions further limit uptake. Without stronger education and infection prevention tools, these barriers will continue to slow growth of the peritoneal dialysis market.
Restraint Impact Analysis*
| Market Restraints | CAGR Contribution | 2026–2028 | 2029–2031 | 2032–2035 |
|---|---|---|---|---|
| Risk of peritonitis, catheter-related infections, and other treatment complications | -1.00% | High | High | Medium |
| Limited patient awareness, inadequate training, and shortage of specialized dialysis professionals | -0.70% | High | Medium | Medium |
| High costs of automated dialysis equipment, consumables, and ongoing treatment supplies | -0.35% | Medium | Medium | High |
| Others – Supply chain disruptions, limited reimbursement coverage, and patient adherence challenges | -0.15% | Low | Low | Low |
Expansion of automated systems and digital remote monitoring
Opportunity
Automated peritoneal dialysis holds a 38% share of the application landscape, and this share can expand as cyclers become smaller, quieter, and more affordable. Remote monitoring platforms allow clinicians to track ultrafiltration, dwell times, blood pressure entries, and alarms, which supports earlier action and lowers emergency visits. This opens opportunities for software features, predictive analytics, and patient engagement tools that complement hardware sales.
Emerging economies in Asia Pacific, Latin America, and the Middle East offer large untreated populations and growing government interest in cost-effective renal care. Companies that combine devices, solutions, training, and digital support into a single home dialysis package are well positioned to capture new patients and build long-term relationships with providers.
Supply chain stability and shortage of trained clinical staff
Challenge
Peritoneal dialysis depends on sterile fluid manufacturing, specialized plastics, and reliable global distribution, so any disruption can quickly affect patients who need daily exchanges. Past hurricane damage to a major manufacturing facility showed how a single site can create shortages across a large region. Solutions represent a 62% share of the peritoneal dialysis market, which makes continuity of supply especially important.
Another challenge is the shortage of nephrologists, surgeons, and nurses trained in catheter insertion and home therapy education. Poorly trained teams contribute to early technique failure and weaker patient confidence. Companies and health systems are responding by diversifying manufacturing locations, building regional inventories, and investing in structured training programs, yet these efforts require time and capital.
-
Download Free Sample to learn more about this report
PERITONEAL DIALYSIS MARKET REGIONAL INSIGHTS
-
North America
North America holds a 28% share of the peritoneal dialysis market. The United States is the main contributor, supported by a federal goal of placing 80% of new kidney failure patients on home dialysis or transplant, and by payment models that reward home therapy. Large dialysis organizations have opened dedicated home training centers, and nurse-led support has improved retention on therapy. Manufacturers headquartered in the region produce solutions, cyclers, and catheters, which supports local supply stability. Canada contributes through provincial home dialysis programs that target remote communities and use telehealth to reduce travel burden. Diabetes remains a leading cause of kidney failure in the region, which keeps patient inflow steady. Technology adoption is high, so connected cyclers and remote monitoring platforms are reaching a growing share of patients.
-
Europe
Europe accounts for a 21% share of the peritoneal dialysis market. Countries such as Denmark, the United Kingdom, and Spain have long supported home dialysis, and assisted peritoneal dialysis programs allow older adults to stay in their own homes with nurse or family help. An aging population drives demand because kidney function declines with age and many patients prefer to avoid frequent hospital trips. National health systems favor cost-effective therapy, which supports peritoneal dialysis in budget-sensitive settings. Germany and France host major manufacturing and research activity, and European regulators encourage safety and quality improvements in solutions and devices. Clinical societies publish guidelines that promote early modality education, and this is raising awareness among patients and referring physicians across the region.
-
Asia-Pacific
Asia Pacific leads the peritoneal dialysis market with a 38% share. China has the largest national patient pool, with approximately 100,000 patients on peritoneal dialysis, and local manufacturers such as Huaren, CR Double-Crane, Qingshan Likang, and Tj Tianan are expanding domestic supply. Hong Kong operates a PD First policy, and more than 70% of its dialysis patients use peritoneal dialysis, which shows how policy can reshape modality choice. Thailand adopted a PD First approach in its universal coverage scheme, and this has expanded access for rural patients. India, Vietnam, and Indonesia show growing demand as kidney disease screening improves. Cost-effective CAPD remains the dominant method in many countries, while APD is expanding in Japan, South Korea, and Australia.
-
Middle East & Africa
Middle East & Africa holds a 7% share of the peritoneal dialysis market. Growth is supported by a rising diabetes burden, expanding hospital infrastructure in Gulf countries, and government programs that seek to move patients from in-center care to home therapy. Saudi Arabia and the United Arab Emirates are investing in nephrology centers and training, and private providers are introducing automated systems. In Africa, peritoneal dialysis is valued for acute kidney injury care because it needs less equipment than hemodialysis, and international programs have supported catheter and solution supply in several countries. Limited trained staff, import dependence, and funding gaps remain barriers, but local partnerships and regional distribution agreements are gradually improving access for patients outside major cities.
-
Rest of the World
Rest of the World holds a 6% share of the peritoneal dialysis market and is anchored by Latin America. Mexico has one of the highest rates of peritoneal dialysis use globally, with public institutions treating most of their dialysis patients through this modality. Brazil and Argentina maintain established programs, and Colombia and Chile have expanded home dialysis education. Public purchasing contracts and regional manufacturing partnerships help control costs. Challenges include uneven access in rural areas and currency pressure on imported equipment. Even so, a strong clinical tradition, lower infrastructure requirements, and growing awareness of chronic kidney disease keep peritoneal dialysis relevant. Eastern Europe and Central Asia within this group also show gradual interest as kidney care investment increases.
KEY INDUSTRY PLAYERS
The peritoneal dialysis market features major global vendors and fast-growing regional manufacturers. Baxter and Fresenius hold broad portfolios covering solutions, cyclers, catheters, and training support, and they compete through connected home dialysis platforms and global supply reach. B. Braun and Terumo strengthen the competitive field through quality manufacturing and specialized products. Chinese players such as Huaren, CR Double-Crane, Qingshan Likang, and Tj Tianan are increasing domestic production, while Renax, Medionics, Newsol, and Bluesail add regional depth. Competitive strategies include capacity expansion, product launches, clinic partnerships, distribution agreements, and digital health integration, all aimed at improving patient retention and strengthening positioning in home dialysis.
LIST OF TOP PERITONEAL DIALYSIS COMPANIES
- Baxter (U.S.)
- Fresenius (Germany)
- B. Braun (Germany)
- Terumo (Japan)
- Huaren (China)
- CR Double-Crane (China)
- Qingshan Likang (China)
- Tj Tianan (U.S.)
- Renax (U.S.)
- Medionics (Canada)
- Bluesail (China)
MARKET LEADERSHIP MATRIX: PERITONEAL DIALYSIS MARKET
| 2×2 Matrix View | Low to Medium Business Strength | High Business Strength |
|---|---|---|
| High Future Growth Potential | Growth Challengers: • Huaren • CR Double-Crane • Qingshan Likang • Bluesail • Newsol |
Leaders: • Baxter • Fresenius • B. Braun • Terumo |
| Low to Medium Future Growth Potential | Emerging/Selective Participants: • Tj Tianan • Renax • Medionics |
Specialized/Niche Players: • Medionics • Renax • Tj Tianan |
LEADER INSIGHTS
- Baxter: José (Joe) E. Almeida, Chairman, President and Chief Executive Officer of Baxter, has emphasized the increasing global need for advanced renal care solutions, driven by rising chronic kidney disease prevalence, aging populations, and the demand for accessible home-based treatment options. His strategic outlook highlights continued investment in renal therapies, innovation, and patient-centered care models that support long-term expansion opportunities in dialysis markets, including peritoneal dialysis. (Published: February 6, 2025 | Source: https://investor.baxter.com)
- Fresenius Medical Care: Helen Giza, Chief Executive Officer of Fresenius Medical Care, has highlighted the importance of expanding patient access to innovative kidney care solutions and improving treatment outcomes through technology-enabled healthcare delivery. Her comments reflect the company’s focus on transforming renal care, increasing adoption of home dialysis approaches, and investing in solutions that address the growing global demand for chronic kidney disease management. (Published: February 20, 2025 | Source: https://freseniusmedicalcare.com/)
- B. Braun: Anna Maria Braun, President and Chief Executive Officer of B. Braun, emphasized that demographic changes, increasing healthcare needs, and advancements in medical technology are creating long-term growth opportunities for healthcare solutions. Her strategic vision highlights continued innovation, investment in medical devices, and development of integrated care solutions that support improved treatment accessibility and evolving renal care requirements. (Published: April 2025 | Source: https://www.bbraun.com/)
INVESTMENT ANALYSIS AND OPPORTUNITIES
Investment in the peritoneal dialysis market is directed toward manufacturing capacity, digital platforms, and patient training infrastructure. Solutions hold a 62% share, so investors view sterile fluid production as a stable and recurring revenue base for suppliers, which encourages new plants and regional supply hubs. Opportunities also exist in connected cyclers, predictive analytics, and decision support tools that help clinicians prevent complications. Asia Pacific, with a 38% regional share, attracts partnerships between global companies and local producers. Private capital is flowing into home dialysis service providers, assisted therapy programs, and telehealth platforms. Companies that integrate devices, consumables, software, and nurse support are expected to gain stronger bargaining power with payers and dialysis organizations.
NEW PRODUCT DEVELOPMENT
Product development in the peritoneal dialysis market focuses on safer therapy, easier use, and better data. Manufacturers are launching cyclers with wireless connectivity, intuitive touchscreens, and cloud platforms that share therapy records with clinics. Automated peritoneal dialysis holds a 38% share of applications, and this is pushing designers toward smaller and quieter machines suitable for travel. In solutions, research is focused on low glucose degradation product bags, neutral pH formulations, and combinations that protect the peritoneal membrane. Pre-connected systems, antimicrobial connectors, and disinfecting caps aim to reduce peritonitis. Pediatric dosing features and assisted therapy modes are also being added, which widens usability across age groups and care settings.
RECENT DEVELOPMENTS
- October 2026: Vantive announces next-generation peritoneal dialysis cycler to expand digitally connected home kidney care. Vantive announced plans to expand HomeAdvantage with its Avira automated peritoneal dialysis cycler, supporting home treatment innovation through connected technology and improved patient management.
- June 2026: Fresenius launches unified digital platform to improve remote monitoring and home dialysis management. Fresenius Medical Care launched kinexus, integrating peritoneal dialysis monitoring, remote prescription management, and supply ordering to strengthen connected home treatment and clinical workflow efficiency.
- February 2026: Qingshan Likang supports clinical research evaluating amino acid peritoneal dialysis solutions for nutritional improvement. Qingshan Likang supported a published clinical study protocol evaluating amino acid-based dialysis solutions, focusing on nutritional outcomes, glucose reduction, and treatment safety in China.
- March 2026: Vantive secures national supply agreement for peritoneal dialysis equipment and consumables in New Zealand. Vantive secured an approved national listing agreement enabling Health New Zealand to purchase its peritoneal dialysis equipment and consumables, supporting treatment access and procurement continuity.
REPORT COVERAGE
This peritoneal dialysis market report covers segmentation by type, application, and region, along with competitive analysis of 12 leading companies. Type coverage includes peritoneal dialysis machines, peritoneal dialysis solutions, and others, with solutions identified as the leading type segment. Application coverage includes CAPD, APD, and others, with CAPD identified as the leading application segment. Regional analysis spans North America, Europe, Asia Pacific, Middle East & Africa, and Rest of the World, with Asia Pacific identified as the leading region. The report also examines drivers, restraints, opportunities, challenges, latest trends, investment prospects, product development activity, and recent company developments that influence the peritoneal dialysis market.
| Attributes | Details |
|---|---|
|
Market Size Value In |
US$ 0.17 Billion in 2026 |
|
Market Size Value By |
US$ 0.29 Billion by 2035 |
|
Growth Rate |
CAGR of 6.1% from 2026 to 2035 |
|
Forecast Period |
2026 - 2035 |
|
Base Year |
2025 |
|
Historical Data Available |
Yes |
|
Regional Scope |
Global |
|
Segments Covered |
|
|
By Types
|
|
|
By Application
|
FAQs
The global Peritoneal Dialysis Market is expected to reach USD 0.29 billion by 2035.
The Peritoneal Dialysis Market is expected to exhibit a CAGR of 6.1% by 2035.
As of 2026, the global Peritoneal Dialysis Market is valued at USD 0.17 billion.
Some of the top companies operating in the market players Baxter (U.S.), Fresenius (Germany), B. Braun (Germany), Terumo (Japan) and Huaren (China) are the top companies operating in the peritoneal dialysis market.
The peritoneal dialysis market is driven by increasing prevalence of chronic kidney disease, rising cases of end-stage renal disease, growing demand for home-based dialysis treatments, expanding healthcare infrastructure, and advancements in automated peritoneal dialysis technologies.
High treatment costs, risks of peritonitis and catheter-related infections, limited patient awareness, and inadequate access to specialized dialysis training restrain peritoneal dialysis market growth.